PT - JOURNAL ARTICLE AU - Vonk, Jet M.J. AU - Morin, Brittany T. AU - Pillai, Janhavi AU - Rolon, David Rosado AU - Bogley, Rian AU - Baquirin, David Paul AU - Ezzes, Zoe AU - Tee, Boon Lead AU - DeLeon, Jessica AU - Wauters, Lisa AU - Lukic, Sladjana AU - Montembeault, Maxime AU - Younes, Kyan AU - Miller, Zachary AU - García, Adolfo M. AU - Mandelli, Maria Luisa AU - Sturm, Virginia E. AU - Miller, Bruce L. AU - Gorno-Tempini, Maria Luisa TI - Digital language markers distinguish frontal from right anterior temporal lobe atrophy in frontotemporal dementia AID - 10.1101/2024.08.29.24312807 DP - 2024 Jan 01 TA - medRxiv PG - 2024.08.29.24312807 4099 - http://medrxiv.org/content/early/2024/08/30/2024.08.29.24312807.short 4100 - http://medrxiv.org/content/early/2024/08/30/2024.08.29.24312807.full AB - Background and Objectives Within frontotemporal dementia (FTD), the behavioral variant (bvFTD) characterized by frontal atrophy, and semantic behavioral variant (sbvFTD) characterized by right anterior temporal lobe (rATL) atrophy, present diagnostic challenges due to overlapping symptoms and neuroanatomy. Accurate differentiation is crucial for clinical trial inclusion targeting TDP-43 proteinopathies. This study investigated whether automated speech analysis can distinguish between FTD-related rATL and frontal atrophy, potentially offering a non-invasive diagnostic tool.Methods In a cross-sectional design, we included 40 participants with FTD-related predominant frontal atrophy (n=16) or predominant rATL atrophy (n=24) and 22 healthy controls from the UCSF Memory and Aging Center. Using stepwise logistic regression and receiver operating characteristic (ROC) curve analysis, we analyzed 16 linguistic and acoustic features that were extracted automatically from audio-recorded picture description tasks. Neuroimaging data were analyzed using voxel-based morphometry to examine brain-behavior relationships of regional atrophy with the features selected in the regression models.Results Logistic regression identified three features (content units, lexical frequency, familiarity) differentiating the overall FTD group from controls (AUC=.973), adjusted for age. Within the FTD group, five features (adpositions/total words ratio, arousal, syllable pause duration, restarts, words containing ‘thing’) differentiated frontal from rATL atrophy (AUC=.943). Neuroimaging analyses showed that semantic features (lexical frequency, content units, ‘thing’ words) were linked to bilateral inferior temporal lobe structures, speech and lexical features (syllable pause duration, adpositions/total words ratio) to bilateral inferior frontal gyri, and socio-emotional features (arousal) to areas known to mediate social cognition including the right insula and bilateral anterior temporal structures. As a composite score, this set of five features was uniquely associated with rATL atrophy.Discussion Automated speech analysis effectively distinguished the overall FTD group from controls and differentiated between frontal and rATL atrophy. The neuroimaging findings for individual features highlight the neural basis of language impairments in these FTD variants, and when considered together, underscore the importance of utilizing features’ combined power to identify impaired language patterns. Automated speech analysis could enhance early diagnosis and monitoring of FTD, offering a scalable, non-invasive alternative to traditional methods, particularly in resource-limited settings. Further research should aim to integrate automated speech analysis into multi-modal diagnostic frameworks.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the National Institutes of Health (M.L. Gorno-Tempini: R01NS050915, K24DC015544; U01AG052943; B.L. Miller: P50AG023501, P01AG019724; J.M.J. Vonk: R00AG066934) and NWO/ZonMw (Veni Grant project number 09150161810017).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All participants or caregivers provided informed consent following procedures aligned with the Declaration of Helsinki, and the study was approved by the University of California San Francisco Institutional Review Board.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe conditions of our ethics approval do not permit public archiving of anonymized study data. Data generated by the UCSF MAC are available upon request. Data requests can be submitted through the UCSF MAC Resource Request form: http://memory.ucsf.edu/resources/data. Access will be granted to named individuals in accordance with ethical procedures governing the reuse of sensitive data. All requests will undergo UCSF regulated procedure thus requiring submission of a Material Transfer Agreement (MTA) which can be found at https://icd.ucsf.edu/material-transfer-and-data-agreements. No commercial use would be approved.